New hope for rare anemia patients: drug may cut transfusions by a third
NCT ID NCT07331818
First seen Jan 12, 2026 · Last updated Apr 29, 2026 · Updated 16 times
Summary
This study tests a drug called luspatercept in 45 people with rare inherited anemias that cause low red blood cells. The goal is to see if it can reduce the need for blood transfusions by at least one third in those who rely on transfusions, or raise hemoglobin levels in those who don't. Participants will receive the drug and be monitored for 12 weeks to measure these changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY RED BLOOD CELL DISORDER (DISORDER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Assistance Publique Hôpitaux de Paris - Hôpital Necker
Paris, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Assistance Publique Hôpitaux de Paris - Hôpital Saint-Louis
Paris, 75010, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Bordeaux-Hôpital Haut-Lévêque
Pessac, 33600, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Hospitalier Universitaire de Montpellier
Montpellier, 34295, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano
Milan, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
GCS Groupement des Hôpitaux de l'Institut Catholique de Lille
Lille, 59800, France
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.